Great reporting by Hari Sreenivasan in this segment on a new - TopicsExpress



          

Great reporting by Hari Sreenivasan in this segment on a new blockbuster drug that has a high curage rate for Hepatitis-C. The rub? It also has a high price: Sovaldi costs $1000 per pill, or $84,000 for the typical course of treatment. Pent up demand and potent results have led to record revenue for the maker of the drug, Gilead Pharmaceuticals, and public outcry about the expense: nytimes/2014/04/23/your-money/gilead-revenue-soars-on-hepatitis-c-drug.html This is a complicated, important story. I thought the PBS NewsHour handled it well.
Posted on: Thu, 24 Apr 2014 00:58:59 +0000

Trending Topics



Recently Viewed Topics




© 2015